Cargando…

Overexpression of Glypican 5 (GPC5) Inhibits Prostate Cancer Cell Proliferation and Invasion via Suppressing Sp1-Mediated EMT and Activation of Wnt/β-Catenin Signaling

Glypican 5 (GPC5) belongs to the family of heparan sulfate proteoglycans (HSPGs). It was initially known as a regulator of growth factors and morphogens. Recently, there have been reports on its correlation with the tumorigenic process in the development of some cancers. However, little is known abo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yu, Xu, Kai, He, Miao, Fan, Guilian, Lu, Hongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844840/ https://www.ncbi.nlm.nih.gov/pubmed/28893348 http://dx.doi.org/10.3727/096504017X15044461944385

Ejemplares similares

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer
por: Campbell, Douglas H., et al.
Publicado: (2018)

Somatic glypican 3 (GPC3) mutations in Wilms' tumour
por: White, G R M, et al.
Publicado: (2002)

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)

Glypican Gene GPC5 Participates in the Behavioral Response to Ethanol: Evidence from Humans, Mice, and Fruit Flies
por: Joslyn, Geoff, et al.
Publicado: (2011)

Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling
por: Hu, Pei, et al.
Publicado: (2018)

Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer
por: Ma, Yanmei, et al.
Publicado: (2021)

Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer
por: Ma, Yanmei, et al.
Publicado: (2022)

Targeted beta therapy of prostate cancer with (177)Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)
por: Yeh, Mei-Chun, et al.
Publicado: (2020)

The novel lncRNA GPC5-AS1 stabilizes GPC5 mRNA by competitively binding with miR-93/106a to suppress gastric cancer cell proliferation
por: Bo, Guo, et al.
Publicado: (2022)

Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a
por: Wang, Siwei, et al.
Publicado: (2016)

Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway
por: MIAO, JUNJIE, et al.
Publicado: (2015)

Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma
por: Yaguchi, Tomonori, et al.
Publicado: (2015)

IMMU-16. TARGETING GLYPICAN 2 (GPC2) ON PEDIATRIC MALIGNANT BRAIN TUMORS WITH MRNA CAR T CELLS
por: Foster, Jessica, et al.
Publicado: (2021)

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma
por: Muralidharan, Sujatha, et al.
Publicado: (2022)

Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
por: Mauro, Montalbano, et al.
Publicado: (2023)

ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration
por: Han, Guo-Dong, et al.
Publicado: (2023)

Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma
por: Zhu, Hanshuo, et al.
Publicado: (2021)

Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling
por: Li, Fuchuan, et al.
Publicado: (2011)

Mutation screening of two candidate genes from 13q32 in families affected with Bipolar disorder: human peptide transporter (SLC15A1) and human glypican5 (GPC5)
por: Maheshwari, Manjula, et al.
Publicado: (2002)

Distinct requirements of wls, wnt9a, wnt5b and gpc4 in regulating chondrocyte maturation and timing of endochondral ossification
por: Ling, Irving TC, et al.
Publicado: (2016)

RASSF4 Overexpression Inhibits the Proliferation, Invasion, EMT, and Wnt Signaling Pathway in Osteosarcoma Cells
por: Zhang, Minglei, et al.
Publicado: (2017)

OCI-5/GPC3, a Glypican Encoded by a Gene That Is Mutated in the Simpson-Golabi-Behmel Overgrowth Syndrome, Induces Apoptosis in a Cell Line–specific Manner
por: Gonzalez, Alfonso Dueñas, et al.
Publicado: (1998)

Glypicans and cytonemes unite to distribute Wnt ligands
por: Waghmare, Indrayani, et al.
Publicado: (2021)

C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway
por: Xu, Duo, et al.
Publicado: (2022)

CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation
por: Kwon, Yeo-Jung, et al.
Publicado: (2016)

Demethylzelasteral inhibits proliferation and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma
por: Yu, Jiarui, et al.
Publicado: (2021)

TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6
por: Lehmkuhl, Erik M., et al.
Publicado: (2021)

GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer
por: Yang, Ming, et al.
Publicado: (2022)

Sanguinarine suppresses migration and metastasis in colorectal carcinoma associated with the inversion of EMT through the Wnt/β‐catenin signaling
por: Zhu, Man, et al.
Publicado: (2020)

Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/β-Catenin Signaling
por: Wang, Chengqin, et al.
Publicado: (2021)

The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer
por: LI, YAN, et al.
Publicado: (2013)

MicroRNA-140-5p suppresses cell proliferation and invasion in gastric cancer by targeting WNT1 in the WNT/β-catenin signaling pathway
por: Cha, Yinlian, et al.
Publicado: (2018)

Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway
por: Zhang, Yunxia, et al.
Publicado: (2020)

Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway
por: Shi, Zhe, et al.
Publicado: (2022)

Glypican-1 Overexpression in Different Types of Breast Cancers
por: Alshammari, Fatemah O F O, et al.
Publicado: (2021)

KLHL22 Regulates the EMT and Proliferation in Colorectal Cancer Cells in Part via the Wnt/β-Catenin Signaling Pathway
por: Song, Yi, et al.
Publicado: (2020)

Wnt5a Suppresses β-catenin Signaling during Hair Follicle Regeneration
por: Xing, Yizhan, et al.
Publicado: (2016)

LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in gastric cancer
por: Wei, Yucai, et al.
Publicado: (2019)

Overexpression of HDAC6 suppresses tumor cell proliferation and metastasis by inhibition of the canonical Wnt/β-catenin signaling pathway in hepatocellular carcinoma
por: Yin, Zhusheng, et al.
Publicado: (2018)

Qingshen Buyang Formula Attenuates Renal Fibrosis in 5/6 Nephrectomized Rats via Inhibiting EMT and Wnt/β-Catenin Pathway
por: Zhang, Xueqin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fbfrm5nrcho74vgr9k3dc1ofnm